Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - INTEREST INCOME & EXPENSE
Interest Income & Expense OCUL - Ocular Therapeutix, Inc.
11.3 M
LAST VALUE
30.37%
2 YEAR CAGR
45.49%
5 YEAR CAGR
38.36%
10 YEAR CAGR